Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAH631 Factorial Study in Essential Hypertension
NCT00311740Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2006
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan, hydrochlorothiazide in essential hypertension, sponsored by Novartis. Started Mar 2006; status: completed.
02
Drugs
valsartanhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00311740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311740.